Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Zealand Pharma
Resolutions from Zealand Pharma's Annual General Meeting 2025
27 mars 2025 13h20 HE
|
Zealand Pharma
Company announcement – No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no....
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
25 mars 2025 12h00 HE
|
Zealand Pharma
Company announcement – No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL)...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
20 mars 2025 12h00 HE
|
Zealand Pharma
Company announcement – No. 5 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”)...
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
17 mars 2025 03h00 HE
|
Zealand Pharma
Press release – No. 4 / 2025 Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity Initiated in December 2024, the...
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
12 mars 2025 02h00 HE
|
Zealand Pharma
Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with...
Zealand Pharma convenes its Annual General Meeting 2025
20 févr. 2025 07h00 HE
|
Zealand Pharma
Company Announcement – No. 3 / 2025 Zealand Pharma convenes its Annual General Meeting 2025 Notice to convene the Annual General Meeting 2025 of Zealand Pharma A/S (CVR no. 20 04 50 78) (the...
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
20 févr. 2025 04h08 HE
|
Zealand Pharma
Company announcement – No. 2 / 2025 Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with...
Zealand Pharma Announces Financial Results for the Full Year 2024
20 févr. 2025 01h00 HE
|
Zealand Pharma
Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity...
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
13 févr. 2025 11h00 HE
|
Zealand Pharma
Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
13 janv. 2025 11h00 HE
|
Zealand Pharma
Company announcement – No. 1 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...